Additionally, abnormal expression of PGRMC2 has been found to be associated with osteoporosis risk, potentially participating in the regulation of the bone immune microenvironment by influencing the differentiation process of monocytes into macrophages. The gene discussed is PGRMC2; the disease is osteoporosis.